Development of Asymmetric Acylation Reaction by Using Chiral Leaving Group and Its Application to the Synthesis of Useful Materials

手性离去基团不对称酰化反应的进展及其在有用材料合成中的应用

基本信息

  • 批准号:
    05680508
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

This research was commenced with the study on asymmetirc reaction by employing chiral leaving group. First, optically active benzimidazole derivative prepared from (R)-mandelic acid was found to serve as an effective chiral leaving group in the asymmetric acylation of achiral amide enolate affording optically active alpha-alkyl-beta-oxoamide in up to 65% ee. This reaction was attempted to apply to the synthesis of a key synthetic intermediate of beta-lactam antibiotics. Although no optical yield was observed in the acylation of beta-lactam enolate, it became obvious that the acylated product, 3-acyl-beta-lactam, racemized easily different from the previous case. This result seemed to suggest the possibility of asymmetric reduction of racemic 3-acyl-beta-lactam by using chiral binap-Ru complex. Asymmetric acylation of allylmetal was found to be difficult though allylcopper was found to be a good reagent for allylation of acid chloride.On the other hands, new synthetic method of chiral imidazole derivatives was developed by using alkylation of carbonyl compounds with the lithiated imidazole bearing chiral tetrahydropyranyl group on nitrogen. The newly prepared imidazole derivatives were examined as chiral ligand in asymmetric reactions. Preliminary study on the mechanism of asymmetric reduction using oxazaborolidine which was developed by Istuno and Corey, suggested another possibility of mechanism for asymmetric induction. In the asymmetric alkylation of benzaldehyde with diethylzinc and chiral ligand of imidazole derivatives, up to 73%ee was achieved by introducing anthracene framework on imidazole derivative.Thus we succeeded in the development of asymmetric acylation of amide enolate by using chiral leaving group along with various new findings concerned with asymmetric reaction. Further studies are in progress.
本研究是从手性离去基团对不对称反应的研究开始的。首先,以(R)-扁桃酸为原料合成了光学活性苯并咪唑衍生物,发现其在非手性酰胺烯醇化物的不对称酰化反应中可作为有效的手性离去基团,得到光学活性α-烷基-β-氧代酰胺,其ee值高达65%,并尝试将该反应应用于β-内酰胺类抗生素的关键合成中间体的合成。虽然在β-内酰胺烯醇化物的酰化中没有观察到光学产率,但很明显,酰化产物3-酰基-β-内酰胺容易外消旋化,与以前的情况不同。这一结果表明手性联萘钌配合物可用于外消旋3-酰基-β-内酰胺的不对称还原。烯丙基铜是酰氯烯丙基化反应的良好试剂,但烯丙基金属的不对称酰化反应比较困难,另一方面,利用含手性四氢吡喃基的锂化咪唑与羰基化合物的烷基化反应,发展了手性咪唑衍生物的合成新方法。研究了新合成的咪唑衍生物作为手性配体在不对称反应中的应用。对Istuno和Corey提出的恶唑硼烷不对称还原反应机理进行了初步研究,提出了不对称诱导反应的另一种可能机理。在咪唑衍生物的手性配体和二乙基锌与苯甲醛的不对称烷基化反应中,通过在咪唑衍生物上引入蒽骨架,获得了高达73%ee的不对称烷基化反应,从而成功地发展了利用手性离去基团沿着的酰胺烯醇化物的不对称酰化反应。进一步的研究正在进行中。

项目成果

期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
尾形 美也子: "Chiral Leaving Group: Synthesis of Optically Active Benz-imidazole and Its Application to Asymmetric Acvlation" Synlett. 728-730 (1993)
Miyako Ogata:“手性离去基团:光学活性苯并咪唑的合成及其在不对称乙酰化中的应用”Synlett 728-730 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大塚和弘、その他: "Catalytic Asymmetric Reduction of Acetophenone Using Optically Active N-Sulfonyloxazaborolidine As a Catalyst" Mem.Fac.Sci.,Kyushu Univ.,Ser.C.19(1). 23-28 (1993)
Kazuhiro Otsuka 等人:“使用光学活性 N-磺酰基恶唑硼烷作为催化剂催化苯乙酮的不对称还原”Mem.Fac.Sci.,九州大学,Ser.C.19(1) (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
K.Otsuka, K.Ito, and T.Katsuki: "Catalytic Asymmetric Reduction of Acetophenone Using Optically Active N-sulfonyloxazaborolidine As a Catalyst" Mem.Fac.Sci., Kyushu Univ., Ser.C.19(1). 23-28 (1993)
K.Otsuka、K.Ito 和 T.Katsuki:“使用光学活性 N-磺酰基恶唑硼烷作为催化剂催化苯乙酮的不对称还原”Mem.Fac.Sci.,九州大学,Ser.C.19(1)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
尾形美也子、その他: "Chiral Leaving Group:Synthesis of Optically Active Benzimidazole and Its Appication to Asymmetric Acylation" Synlett. 728-729 (1993)
Miyako Ogata 等人:“手性离去基团:光学活性苯并咪唑的合成及其在不对称酰化中的应用”Synlett 728-729 (1993)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大塚 和宏、その他: "Boran O-Adduct Can Be an Intermediate in Chral N-Sulfonyloxazaborolidine-Catalyzed Enantioselective Reduction of Ketones" Synlett. (in press). (1995)
Kazuhiro Otsuka 等人:“Boran O-加合物可以成为 Chral N-磺酰基恶唑硼烷催化对映酮还原的中间体”Synlett(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATSUKI Tsutomu其他文献

KATSUKI Tsutomu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATSUKI Tsutomu', 18)}}的其他基金

Development of environment-conscious synthetic reactions : construction of reaction coordinate-response catalyst
环境意识合成反应的发展:反应配位响应催化剂的构建
  • 批准号:
    18002011
  • 财政年份:
    2006
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Specially Promoted Research
Dynamic Stereocontrol
动态立体控制
  • 批准号:
    10208104
  • 财政年份:
    1998
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas (B)
Stereocontrol utilizing intermolecular interaction
利用分子间相互作用的立体控制
  • 批准号:
    10208214
  • 财政年份:
    1998
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas (B)
Exploitation of Practical Method for Asymmetric Functionalization of Alkenes
烯烃不对称官能化实用方法的开发
  • 批准号:
    09554048
  • 财政年份:
    1997
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanistic Study on Asymmetric Oxidations with Metallosalen Complexes as Catalysts and Exploitation of New Metallosalen Complexes
金属Salen配合物催化剂不对称氧化机理研究及新型金属Salen配合物的开发
  • 批准号:
    09440220
  • 财政年份:
    1997
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of the effecient synthetic methods of some pharmeceuticals by using the generalized asymmetric epoxidation
利用广义不对称环氧化开发一些药物的有效合成方法
  • 批准号:
    06558093
  • 财政年份:
    1994
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Study on Stereocontrol in Sigmatropic Rearrangement
Sigmatropic重排立体控制研究
  • 批准号:
    01540455
  • 财政年份:
    1989
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development and Functional Evaluation of Cyclic Pyrrole-Imidazole Polyamides for Anticancer Drug Applications
用于抗癌药物应用的环状吡咯-咪唑聚酰胺的开发和功能评价
  • 批准号:
    22KJ1695
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Study of biosynthesis and biological functions of imidazole dipeptides in fishes
鱼类咪唑二肽的生物合成及生物学功能研究
  • 批准号:
    23K05035
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular Mechanism of Imidazole Dipeptide for Improvement of Social Function
咪唑二肽改善社会功能的分子机制
  • 批准号:
    22KJ1469
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Enantioselective Pd-Catalyzed Reactions Enabled by Imidazole-based Chiral Biaryl Ligands
咪唑基手性联芳基配体实现对映选择性 Pd 催化反应
  • 批准号:
    2154071
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
Market Assessment of Therapeutic Coordination Polymers Containing Pharmaceuticals and Bis-Imidazole Linkers for Drug Release Applications
用于药物释放应用的含有药物和双咪唑连接体的治疗性配位聚合物的市场评估
  • 批准号:
    570983-2022
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Idea to Innovation
Research Initiation Award: Microwave Synthesis of Imidazole Compounds to Investigate Allosteric Binding to VCP
研究启动奖:微波合成咪唑化合物以研究 VCP 的变构结合
  • 批准号:
    2000028
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
Development of reactive sulfurized imidazole - metabolomics; New phases in Redox Biology.
反应性硫化咪唑的开发-代谢组学;
  • 批准号:
    20K21256
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The Impact of the gut microbiota-dependent metabolite imidazole propionate on the progression of heart failure
肠道微生物群依赖性代谢物丙酸咪唑对心力衰竭进展的影响
  • 批准号:
    436269184
  • 财政年份:
    2019
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Research Fellowships
Enantioselective Catalysis Enabled by Imidazole-Based Biaryl Ligands
基于咪唑的联芳基配体实现对映选择性催化
  • 批准号:
    1900299
  • 财政年份:
    2019
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Standard Grant
Development of novel immune checkpoint blockade using alkylating pyrrole-imidazole polyamides
使用烷基化吡咯-咪唑聚酰胺开发新型免疫检查点阻断剂
  • 批准号:
    19K17846
  • 财政年份:
    2019
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了